Search clinical trials for: coronary stents

Total 10216 results

Unity Health Toronto

Unknown

Revascularization StrategIes for ST Elevation Myocardial Infarction Trial (ASSIST-MI)

ST Elevation Myocardial Infarction | Coronary Stenting | Primary Angioplasty
Lawson Health Research Institute
Canada Foundation for Innovation; Ontario Innovative Trust; Ontario Research...

Completed

Coronary Stenting and Coronary Bypass Grafting at the Same Time in a Specialty Built Operating Room

Coronary Artery Disease

Canada
Deutsches Herzzentrum Muenchen
Technical University of Munich

Completed

ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography (ORSIRO_OCT)

Coronary Heart Disease

Germany
Thorax Centrum Twente

Completed

Change of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome (CHANGE DAPT)

Acute Coronary Syndrome | Percutaneous Coronary Intervention | Drug-Eluting Stents

Netherlands
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Effectiveness of Clopidogrel Resinate in PCI(PRIDE)

Coronary Artery Disease

Korea, Republic of
Shandong Branden Med.Device Co.,Ltd
Fudan University

Unknown

Cordimax China Post Market Surveillance

Coronary Artery Stenosis

China
Medtronic Vascular

Completed

Bare Metal Bifurcation Stent Clinical Trial in Humans (BRANCH)

Myocardial Ischemia | Coronary Artery Disease

New Zealand
Seoul National University Hospital
Medtronic

Unknown

Effect and Efficacy of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerosis (HOST-ONYX)

Myocardial Infarction | Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome

Korea, Republic of
Universitaire Ziekenhuizen KU Leuven
Biosensors International

Unknown

COmplex BifuRcation Lesions: a Comparison Between the AXXESS Device and Culotte Stenting: an Optical Coherence Tomography (OCT) Study (COBRA)

True Coronary Bifurcation Lesions

Belgium
Fortis Escorts Heart Institute
Boston Scientific Corporation; Max Neeman Medical International Ltd.

Completed

Trial on Safety & Performance of TAXUS Element vs. XIENCE Prime Stent in Treatment of Coronary Lesion in Diabetics (Tuxedo)

Type 2 Diabetes | Coronary Heart Disease

India
Boston Scientific Corporation

Completed

A Randomized, Double-blind Study to Assess Paclitaxel-eluting Stents in Treatment of Longer Lesions (TAXUS VI)

Coronary Artery Disease

Germany
R&D Cardiologie
Biotronik SE & Co. KG

Unknown

Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions (PRISON-IV)

Coronary Artery Disease | Coronary Disease | Coronary Stenosis

Netherlands, Belgium
Medtronic Bakken Research Center

Completed

Assessment of Clinical Performance and Costs of the Endeavor Resolute Stent "in Real Life" in Spain. (REDES)

Coronary Artery Disease

Spain
Boston Scientific Corporation

Completed

A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent

Coronary Artery Disease

Italy
Seung-Jung Park
CardioVascular Research Foundation, Korea

Terminated

Drug-eluting Stents vs. Drug-coated Balloon for Preventing Recurrent In-stent Restenosis (RESTORE)

Coronary Restenosis

Korea, Republic of
Seung-Jung Park
Abbott; CardioVascular Research Foundation, Korea

Terminated

LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery)

Coronary Artery Disease

Korea, Republic of
Heart Centre Rotenburg
B. Braun Melsungen AG; Clinical Research Institute Rotenburg a.d.F.

Completed

Paclitaxel-Eluting Balloon Angioplasty and Coroflex™-Stents in the Treatment of Bifurcated Coronary Lesions (PEPCAD V)

Ischemia | Stenosis

Germany
Gangnam Severance Hospital

Completed

Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting Stents (OPTIMA-C)

Ischemic Heart Disease
Thorax Centrum Twente

Unknown

Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents (BIONYX)

Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Unstable Angina Pectoris | Coronary Stenosis | Coronary Restenosis

Netherlands, Israel, Belgium
Boston Scientific Corporation

Completed

Comparative Registry of the PROmus™, ENdeavor™ and CYpher™ Drug Eluting Stents (ProEnCy)

Percutaneous Coronary Intervention

Germany
Boston Scientific Corporation

Completed

Non-inferiority Trial to Assess the Safety and Performance of the Evolution Coronary Stent (Evolve)

Coronary Artery Disease

Spain, Belgium, France, Australia, United Kingdom, Sweden, New Zealand, Denmark, Poland
Boston Scientific Corporation
Pharmaceutical Research Associates

Completed

TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System European Post-Approval Surveillance Study (TE-Prove) (TE-Prove)

Coronary Heart Disease

Spain, Belgium, Latvia, United Kingdom, Germany, France, Ireland, Italy, Poland, Hungary
Boston Scientific Corporation
Pharmaceutical Research Associates; Medidata Solutions

Completed

PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study (PE-Prove)

Coronary Heart Disease

Spain, Ireland, Denmark, United Kingdom, Belgium, Germany, France, Netherlands, Italy, Austria, Hungary
Associations for Establishment of Evidence in Interventions

Unknown

Japan Unprotected Left Main Coronary Artery Disease Percutaneous Coronary Intervention (PCI) Strategy On New Generation Stents (J-LESSON)

Coronary Artery Disease

Japan
Jordan Collaborating Cardiology Group
AstraZeneca

Completed

The First Jordanian PCI Registry: Events at 1 Year (JoPCR1)

Percutaneous Coronary Intervention

Jordan
Xijing Hospital
Nanjing First Hospital, Nanjing Medical University

Unknown

Clinical Performance of Nano Plus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

Coronary Artery Disease

China
Azienda Ospedaliera Città della Salute e della...

Unknown

Self-apposing Stentys Stents Registry (SPARTA)

Coronary Artery Disease

Italy, Malaysia, Poland
Medical Care Center Prof. Mathey, Prof. Schofer...
Abbott Medical Devices

Completed

ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (ASSURE)

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive Diseases | Coronary Stenosis | Coronary Restenosis

Germany
Lepu Medical Technology (Beijing) Co., Ltd.

Unknown

NeoVas Bioresorbable Coronary Scaffold Randomized Controlled Trial

Coronary Artery Disease

China
Amaranth Medical Inc.

Unknown

Safety and Efficacy Study of the Amaranth Medical MAGNITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT III) (RENASCENT III)

Myocardial Ischemia | Coronary Artery Disease

Italy, Colombia
Centre de Recherche de l'Institut Universitaire...
Canadian Institutes of Health Research (CIHR); Boston Scientific Corporation

Terminated

Sealing Moderate Coronary Saphenous VEin Graft Lesions With Paclitaxel-Eluting Stents (VELETI II)

Coronary Artery Bypass Grafting

Canada
Aarhus University Hospital Skejby
Johnson & Johnson

Completed

Nordic Bifurcation Study. How to Use Drug Eluting Stents (DES) in Bifurcation Lesions? (BIFI)

Coronary Artery Disease

Denmark
Biotronik AG

Completed

Clinical Performance of the Pantera Lux Balloon Versus the Orsiro Stent in Patients With In-stent Restenosis. (BIOLUX-RCT)

Coronary Artery Disease | Coronary Restenosis

Germany, Latvia
Teikyo University

Unknown

Prospective Multicenter Registry of Hybrid Coronary Artery Revascularization Combined With Surgical Bypass and Percutaneous Coronary Intervention Using Everolimus Eluting Metallic Stents

Coronary Artery Disease
University Heart Center Freiburg - Bad Krozingen

Completed

Culotte Technique Versus TAP Stunting for the Treatment of de Novo Coronary Bifurcation Lesion With Drug-eluting Stents (BBK2)

Coronary Artery Disease | Restenosis

Germany
Johannes Gutenberg University Mainz

Completed

Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study (EST)

Coronary Artery Disease

Germany
Abbott Medical Devices

Completed

XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Coronary Occlusion | Coronary Restenosis | Vascular Disease | Coronary Artery Stenosis | Thrombosis (Stent Thrombosis)

China
Korea University Anam Hospital
Samjin Pharmaceutical Co., Ltd.

Unknown

Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI (ROSUVA-30)

Cardiovascular Diseases | Coronary Artery Disease | Coronary Disease

Korea, Republic of
Yonsei University

Completed

Comparison of Biodegradable Stents: Orsiro and BioMatrix

Percutaneous Coronary Intervention | All-comer

Korea, Republic of
Yonsei University

Completed

Impact of IntraVascular UltraSound Guidance on Outcomes of Xience Prime Stents in Long Lesions (IVUS-XPL Study)

Coronary Artery Disease

Korea, Republic of
Seoul National University Hospital
Abbott

Unknown

Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronary Atherosclerosis (HOST-ALPINE)

Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Percutaneous Coronary Intervention

Korea, Republic of
Yonsei University

Completed

Serial EValuation of multiplE Coronary Artery Diseases by an Optical Coherence Tomography; Assessment of the Changes of de Novo Lesions and Comparisons of Neointimal Coverage Between Xience Prime® Versus Cypher SelectTM Stents; SEVEN-Xience Study

Multi-vessel Diseases, Angina

Korea, Republic of
Yonsei University

Completed

Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents

Stable Angina or Acute Coronary Syndrome Considered for Percutaneous Coronary Intervention With Dyslipidemia or Hypertension

Korea, Republic of
North Texas Veterans Healthcare System

Terminated

Serial Evaluation of Drug-Eluting Stents Using OCT (STRUT-OCT) (STRUT-OCT)

Optical Coherence Tomography (OCT) | Percutaneous Coronary Intervention (PCI) | Drug Eluting Stents (DES) | Uncovered and Malapposed Stent Struts

United States
Abbott Medical Devices

Completed

SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Thailand, Israel, Spain, Italy, United Kingdom, Malaysia, Austria, France, Germany, Poland
Stentys

Unknown

Clinical Study to Evaluate the STENTYS Xposition S for Treatment of Unprotected Left Main Coronary Artery Disease (TRUNC)

Coronary Artery Disease (Left Main)

Italy, Switzerland, United Kingdom
Amaranth Medical Inc.

Unknown

Safety and Efficacy Study of the Amaranth Medical APTITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT II)

Myocardial Ischemia | Coronary Artery Disease

Colombia, Italy
Amaranth Medical Inc.

Unknown

Feasibility Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent (MEND II)

Myocardial Ischemia | Coronary Artery Disease

Colombia
Amaranth Medical Inc.

Unknown

Safety and Efficacy Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT)

Myocardial Ischemia | Coronary Artery Disease

Italy
Medtronic Vascular

Completed

Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease

China

Search clinical trials for: coronary stents

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations